TAK-029
TAK-029 is a potent GP IIb/IIIa antagonist. TAK-029 has potent antithrombotic effects with bleeding time (BT) prolongation in arterial thrombosis models. TAK-029 can be used for the research of various arterial thrombotic diseases[1].
Product Specifications
CAS Number
176655-58-6
UNSPSC
12352005
Target
Integrin
Type
Reference compound
Related Pathways
Cytoskeleton
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/tak-029.html
Smiles
O=C(CNC(C1=CC=C(C(N)=N)C=C1)=O)N([C@H]2CC(OC)=O)CCN(CC(O)=O)C2=O
Molecular Formula
C19H23N5O7
Molecular Weight
433.42
References & Citations
[1]Kawamura M, et al. Effects of TAK-029, a novel GPIIb/IIIa antagonist, on arterial thrombosis in guinea pigs, dogs and monkeys. Thromb Res. 1997 May 15;86 (4) :275-85.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 1
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
OR1061864-01 100 mg
4,4',4''- (((1,3,5-Triazine-2,4,6-triyl) tris (benzene-4,1-diyl) ) tris (ethyne-2,1-diyl) ) trianiline
Sign In for Pricing
View Details OR1061864-02 250 mg
4,4',4''- (((1,3,5-Triazine-2,4,6-triyl) tris (benzene-4,1-diyl) ) tris (ethyne-2,1-diyl) ) trianiline
Sign In for Pricing
View Details OR1061864-03 1 g
4,4',4''- (((1,3,5-Triazine-2,4,6-triyl) tris (benzene-4,1-diyl) ) tris (ethyne-2,1-diyl) ) trianiline
Sign In for Pricing
View Details 
MBS8116995-01 0.3 mg
Mouse Prostatic Acid Phosphatase HEK293 Overexpression Lysate
Sign In for Pricing
View Details MBS8116995-02 5x 0.3 mg
Mouse Prostatic Acid Phosphatase HEK293 Overexpression Lysate
Sign In for Pricing
View Details